Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 3/20 | 0.79 |
| ▸ | ALOX5 | P09917 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | TNKS | O95271 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | HK2 | P52789 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2914750 | 0.84 | TNKS2 (0.51) | TNKS2ALOX5BACE1LTA4HPDE4B | |
| SCHEMBL2914283 | 0.82 | TNKS2 (0.86) | TNKS2ALOX5KDM4EGAAMAPT | |
| SCHEMBL2914798 | 0.81 | TNKS2 (0.63) | TNKS2ALOX5KDM4EGAAMAPT | |
| SCHEMBL2916168 | 0.80 | TNKS2 (0.49) | TNKS2GAABACE1LTA4HPDE4B | |
| SCHEMBL510185 | 0.77 | BACE1 (0.54) | GAABACE1PDE4BHK2PDE4D | |
| SCHEMBL10931154 | 0.77 | PTPN1 (0.51) | TNKS2ALOX5BACE1PDE4B | |
| SCHEMBL9178161 | 0.77 | PTPN1 (0.51) | TNKS2ALOX5BACE1PDE4B | |
| SCHEMBL2910937 | 0.77 | GAA (0.47) | TNKS2KDM4EGAAMAPTBACE1 | |
| SCHEMBL18906736 | 0.76 | TNKS2 (0.75) | TNKS2ALOX5KDM4EAKR1B1TNKS | |
| SCHEMBL9182437 | 0.76 | PTPN1 (0.50) | TNKS2ALOX5MAPTBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2110370-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-1348686-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-03-03 | — | — | EP | disclosed |
| EP-2110370-A1 | Method of producing p-hydroxyphenylalkanols | Sumitomo Chemical Company, Limited (JP) | 2009-10-21 | — | — | EP | disclosed |
| US-6717020-B2 | HIGH YIELD REACTION OF PHENOLS AND UNSATURATED ALCOHOLS IN PRESENCE OF SUCH AS TITANIUM TETRAETHOXIDE AND SODIUM METHOXIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-04-06 | — | — | US | disclosed |
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-10-16 | — | — | US | disclosed |
| EP-1348686-A1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | ADH1C, NR1H3, ADH5 | TNKS2 3493/4885ALOX5 418/4885KDM4E 3412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.